Bank of New York Mellon’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-307,764
Closed -$936K 4174
2024
Q4
$936K Sell
307,764
-18,519
-6% -$56.3K ﹤0.01% 3189
2024
Q3
$1.69M Sell
326,283
-46,732
-13% -$243K ﹤0.01% 2833
2024
Q2
$959K Buy
373,015
+68,451
+22% +$176K ﹤0.01% 3223
2024
Q1
$1.5M Sell
304,564
-30,621
-9% -$151K ﹤0.01% 2923
2023
Q4
$2.95M Sell
335,185
-50,476
-13% -$444K ﹤0.01% 2634
2023
Q3
$4.42M Buy
385,661
+13,152
+4% +$151K ﹤0.01% 2384
2023
Q2
$9.43M Buy
372,509
+63,130
+20% +$1.6M ﹤0.01% 1974
2023
Q1
$9.97M Sell
309,379
-3,316
-1% -$107K ﹤0.01% 1934
2022
Q4
$5.77M Buy
312,695
+3,533
+1% +$65.2K ﹤0.01% 2261
2022
Q3
$8.35M Buy
309,162
+50,198
+19% +$1.36M ﹤0.01% 2002
2022
Q2
$3.58M Sell
258,964
-15,575
-6% -$215K ﹤0.01% 2497
2022
Q1
$5.35M Sell
274,539
-1,705
-0.6% -$33.3K ﹤0.01% 2385
2021
Q4
$4.51M Buy
276,244
+5,691
+2% +$92.9K ﹤0.01% 2519
2021
Q3
$7.54M Buy
270,553
+19,775
+8% +$551K ﹤0.01% 2275
2021
Q2
$7.43M Sell
250,778
-125,820
-33% -$3.73M ﹤0.01% 2286
2021
Q1
$10.5M Buy
376,598
+18,676
+5% +$522K ﹤0.01% 2056
2020
Q4
$10.1M Buy
357,922
+44,618
+14% +$1.26M ﹤0.01% 2000
2020
Q3
$7.88M Buy
313,304
+33,933
+12% +$853K ﹤0.01% 1978
2020
Q2
$6.82M Buy
279,371
+17,513
+7% +$428K ﹤0.01% 2053
2020
Q1
$3.88M Sell
261,858
-66,006
-20% -$977K ﹤0.01% 2205
2019
Q4
$5.32M Sell
327,864
-746,842
-69% -$12.1M ﹤0.01% 2309
2019
Q3
$14M Sell
1,074,706
-1,179,091
-52% -$15.3M ﹤0.01% 1740
2019
Q2
$29.2M Sell
2,253,797
-38,988
-2% -$506K 0.01% 1312
2019
Q1
$36.1M Sell
2,292,785
-249,457
-10% -$3.93M 0.01% 1180
2018
Q4
$51.2M Buy
2,542,242
+77,625
+3% +$1.56M 0.02% 865
2018
Q3
$61.2M Buy
2,464,617
+519,938
+27% +$12.9M 0.02% 883
2018
Q2
$53.4M Sell
1,944,679
-68,553
-3% -$1.88M 0.01% 956
2018
Q1
$62M Sell
2,013,232
-131,437
-6% -$4.05M 0.02% 862
2017
Q4
$76.7M Buy
2,144,669
+135,356
+7% +$4.84M 0.02% 763
2017
Q3
$55.4M Sell
2,009,313
-70,249
-3% -$1.94M 0.02% 917
2017
Q2
$54.9M Buy
2,079,562
+261,764
+14% +$6.91M 0.02% 904
2017
Q1
$37.8M Sell
1,817,798
-123,932
-6% -$2.58M 0.01% 1137
2016
Q4
$40.2M Buy
1,941,730
+18,622
+1% +$385K 0.01% 1070
2016
Q3
$31.2M Sell
1,923,108
-195,450
-9% -$3.17M 0.01% 1170
2016
Q2
$28.8M Buy
2,118,558
+152,383
+8% +$2.07M 0.01% 1170
2016
Q1
$34.3M Sell
1,966,175
-43,392
-2% -$758K 0.01% 1067
2015
Q4
$68.6M Buy
2,009,567
+98,080
+5% +$3.35M 0.02% 709
2015
Q3
$56.9M Buy
1,911,487
+71,346
+4% +$2.12M 0.02% 780
2015
Q2
$58.8M Buy
1,840,141
+675,847
+58% +$21.6M 0.02% 817
2015
Q1
$24.1M Buy
1,164,294
+140,872
+14% +$2.92M 0.01% 1356
2014
Q4
$17.3M Buy
1,023,422
+939,438
+1,119% +$15.9M ﹤0.01% 1572
2014
Q3
$1.62M Sell
83,984
-25,443
-23% -$492K ﹤0.01% 3019
2014
Q2
$3.72M Buy
109,427
+91,133
+498% +$3.1M ﹤0.01% 2505
2014
Q1
$576K Buy
+18,294
New +$576K ﹤0.01% 3528